Cannabinoid improves survival rates of mice with pancreatic cancer

July 30, 2018, Queen Mary, University of London
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain

Mice with pancreatic cancer that were treated with a naturally occurring constituent of medicinal cannabis alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone, a new study reports.

The study is published in the journal Oncogene and was led by Queen Mary University of London and Curtin University, Australia. It tested the impact of the cannabinoid Cannabidiol (CBD) on the use of the commonly used chemotherapy medication Gemcitabine as a treatment for pancreatic in mice.

Each year around 9,800 people in the UK are diagnosed with pancreatic cancer. The disease is particularly aggressive and has one of the lowest survival rate of all cancers.

Lead researcher Professor Marco Falasca from Queen Mary University of London said: "This is a remarkable result. We found that mice with pancreatic cancer survived nearly three times longer if a constituent of medicinal cannabis was added to their chemotherapy treatment.

"Cannabidiol is already approved for use in clinics, which means we can quickly go on to test this in human clinical trials. If we can reproduce these effects in humans, cannabidiol could be in use in cancer clinics almost immediately, compared to having to wait for authorities to approve a new drug.

"The life expectancy for pancreatic cancer patients has barely changed in the last 40 years because there are very few, and mostly only palliative care, treatments available. Given the five-year survival rate for people with cancer is less than seven per cent, the discovery of new treatments and therapeutic strategies is urgently needed."

The cannabinoid CBD does not cause psychoactive effects, as opposed to tetrahydrocannabinol (THC) - the cannabinoid known to cause the psychoactive effects in cannabis. As such, CBD is already cleared for use in the clinic, and does not face the same challenges as products including cannabis oil, which contain controlled substances such as THC.

The researchers add that CBD is also known to improve the side effects of chemotherapy, including nausea, diarrhoea, vomiting, meaning it could also improve the quality of life of patients undergoing .

The research was supported by the UK charity Pancreatic Cancer Research Fund and the Avner Pancreatic Cancer Foundation and also involved researchers from The Beatson Institute for Cancer Research in Scotland.

The study only looked at the effect of this in mice, and clinical trials in humans are needed to confirm whether or not CBD improves of patients.

Explore further: Breath tests may allow for earlier detection of pancreatic cancer

More information: R. Ferro et al. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine, Oncogene (2018). DOI: 10.1038/s41388-018-0390-1

Related Stories

Breath tests may allow for earlier detection of pancreatic cancer

July 18, 2018
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS (British Journal of Surgery) study indicates that breath analyses may help detect pancreatic cancer earlier, ...

Chemoradiotherapy before surgery may extend lives of pancreatic cancer patients

June 5, 2018
Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery, according to unpublished clinical trial results.

Major pancreatic cancer breakthrough

June 5, 2018
Clinical trial results presented today at a prestigious cancer meeting in Chicago show substantial increased survival rates for pancreatic cancer patients who received a four-drug chemotherapy combination known as mFOLFIRINOX ...

Researchers modify common flu virus to attack pancreatic cancer

January 24, 2018
A modified flu virus has now been used in experiments to successfully inhibit the growth of pancreatic cancer, according to an early study by Queen Mary University of London.

Two-drug regimen shows promise against pancreatic cancer

June 4, 2016
A combination of two chemotherapy drugs has shown promising results in fighting pancreatic cancer, significantly improving five-year survival rates, according to a European study presented Friday.

Reason for pancreatic cancer's resistance to chemotherapy found

November 21, 2016
A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy.

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym518498
not rated yet Jul 30, 2018
see I knew pot was a wonder drug

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.